X-151742637-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4BP6_ModerateBS2
The NM_005140.3(CNGA2):c.584G>A(p.Arg195His) variant causes a missense change. The variant allele was found at a frequency of 0.000111 in 1,192,254 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 41 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000046 ( 0 hom., 2 hem., cov: 20)
Exomes 𝑓: 0.00012 ( 0 hom. 39 hem. )
Consequence
CNGA2
NM_005140.3 missense
NM_005140.3 missense
Scores
4
7
6
Clinical Significance
Conservation
PhyloP100: 6.55
Genes affected
CNGA2 (HGNC:2149): (cyclic nucleotide gated channel subunit alpha 2) The protein encoded by this gene represents the alpha subunit of a cyclic nucleotide-gated olfactory channel. The encoded protein contains a carboxy-terminal leucine zipper that mediates channel formation. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.36526296).
BP6
Variant X-151742637-G-A is Benign according to our data. Variant chrX-151742637-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2661651.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNGA2 | NM_005140.3 | c.584G>A | p.Arg195His | missense_variant | 6/7 | ENST00000329903.5 | NP_005131.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNGA2 | ENST00000329903.5 | c.584G>A | p.Arg195His | missense_variant | 6/7 | 5 | NM_005140.3 | ENSP00000328478.4 |
Frequencies
GnomAD3 genomes AF: 0.0000456 AC: 5AN: 109711Hom.: 0 Cov.: 20 AF XY: 0.0000626 AC XY: 2AN XY: 31959
GnomAD3 genomes
AF:
AC:
5
AN:
109711
Hom.:
Cov.:
20
AF XY:
AC XY:
2
AN XY:
31959
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000395 AC: 7AN: 177155Hom.: 0 AF XY: 0.0000323 AC XY: 2AN XY: 61957
GnomAD3 exomes
AF:
AC:
7
AN:
177155
Hom.:
AF XY:
AC XY:
2
AN XY:
61957
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000117 AC: 127AN: 1082543Hom.: 0 Cov.: 27 AF XY: 0.000112 AC XY: 39AN XY: 348907
GnomAD4 exome
AF:
AC:
127
AN:
1082543
Hom.:
Cov.:
27
AF XY:
AC XY:
39
AN XY:
348907
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000456 AC: 5AN: 109711Hom.: 0 Cov.: 20 AF XY: 0.0000626 AC XY: 2AN XY: 31959
GnomAD4 genome
AF:
AC:
5
AN:
109711
Hom.:
Cov.:
20
AF XY:
AC XY:
2
AN XY:
31959
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
3
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 07, 2024 | The c.584G>A (p.R195H) alteration is located in exon 6 (coding exon 5) of the CNGA2 gene. This alteration results from a G to A substitution at nucleotide position 584, causing the arginine (R) at amino acid position 195 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | CNGA2: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Pathogenic
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at